Cyclopharm Ltd Cash Flow Conversion Efficiency
Cyclopharm Ltd cash flow conversion efficiency. Based on the latest financial reports, Cyclopharm Ltd (CYC) has a cash flow conversion efficiency ratio of -0.241x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.69 Million ≈ $-5.44 Million USD) by net assets (AU$31.86 Million ≈ $22.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cyclopharm Ltd (2005–2025)
Cash flow conversion efficiency of Cyclopharm Ltd from 2005 to 2025. This chart illustrates how Cyclopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Cyclopharm Ltd for real-time trading data and today's change.
Cyclopharm Ltd Cash Flow Conversion Ratio Explained
Cyclopharm Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cyclopharm Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cyclopharm Ltd ranked by their cash flow conversion efficiency. Also see market cap of Cyclopharm Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inbest Prime VI Inmuebles Socimi SA
MC:YINB6
|
0.017x |
|
AbL Diagnostics SA
PA:ABLD
|
0.063x |
|
Train Alliance Sweden AB Series B
ST:TRAIN-B
|
-0.047x |
|
FarGlory Hotel Co Ltd
TW:2712
|
0.038x |
|
NDL Ventures Limited
NSE:NDLVENTURE
|
0.000x |
|
Tidehold Development Co Ltd
TW:9902
|
0.079x |
|
PCF Group SA
WAR:PCF
|
0.081x |
|
EUDA Health Holdings Limited
NASDAQ:EUDA
|
0.569x |
Annual Cash Flow Conversion Efficiency for Cyclopharm Ltd (2005–2025)
The table below shows the annual cash flow conversion efficiency of Cyclopharm Ltd from 2005 to 2025. Review CYC free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | AU$27.11 Million ≈ $19.18 Million |
AU$-17.33 Million ≈ $-12.26 Million |
-0.639x | -117.21% |
| 2024-12-31 | AU$42.73 Million ≈ $30.23 Million |
AU$-12.57 Million ≈ $-8.90 Million |
-0.294x | -31.89% |
| 2023-12-31 | AU$32.26 Million ≈ $22.83 Million |
AU$-7.20 Million ≈ $-5.09 Million |
-0.223x | -43.52% |
| 2022-12-31 | AU$36.54 Million ≈ $25.85 Million |
AU$-5.68 Million ≈ $-4.02 Million |
-0.155x | -310.91% |
| 2021-12-31 | AU$43.07 Million ≈ $30.47 Million |
AU$-1.63 Million ≈ $-1.15 Million |
-0.038x | +92.75% |
| 2020-12-31 | AU$17.12 Million ≈ $12.11 Million |
AU$-8.93 Million ≈ $-6.32 Million |
-0.522x | -2375.37% |
| 2019-12-31 | AU$23.20 Million ≈ $16.42 Million |
AU$-489.34K ≈ $-346.24K |
-0.021x | +67.59% |
| 2018-12-31 | AU$17.02 Million ≈ $12.04 Million |
AU$-1.11 Million ≈ $-783.51K |
-0.065x | -64.56% |
| 2017-12-31 | AU$17.25 Million ≈ $12.21 Million |
AU$-682.12K ≈ $-482.64K |
-0.040x | -175.26% |
| 2016-12-31 | AU$12.46 Million ≈ $8.82 Million |
AU$654.79K ≈ $463.31K |
0.053x | -83.43% |
| 2015-12-31 | AU$13.10 Million ≈ $9.27 Million |
AU$4.15 Million ≈ $2.94 Million |
0.317x | -44.96% |
| 2014-12-31 | AU$7.76 Million ≈ $5.49 Million |
AU$4.47 Million ≈ $3.16 Million |
0.576x | +198.54% |
| 2013-12-31 | AU$3.66 Million ≈ $2.59 Million |
AU$706.71K ≈ $500.04K |
0.193x | +715.72% |
| 2012-12-31 | AU$15.61 Million ≈ $11.04 Million |
AU$369.29K ≈ $261.29K |
0.024x | -38.69% |
| 2011-12-31 | AU$14.60 Million ≈ $10.33 Million |
AU$563.63K ≈ $398.80K |
0.039x | +684.06% |
| 2010-12-31 | AU$13.77 Million ≈ $9.74 Million |
AU$-90.96K ≈ $-64.36K |
-0.007x | -102.49% |
| 2009-12-31 | AU$13.93 Million ≈ $9.86 Million |
AU$3.69 Million ≈ $2.61 Million |
0.265x | +132.81% |
| 2008-12-31 | AU$13.06 Million ≈ $9.24 Million |
AU$1.49 Million ≈ $1.05 Million |
0.114x | +472.02% |
| 2007-12-31 | AU$7.34 Million ≈ $5.20 Million |
AU$146.10K ≈ $103.37K |
0.020x | +100.96% |
| 2006-12-31 | AU$-566.06K ≈ $-400.52K |
AU$1.17 Million ≈ $827.14K |
-2.065x | -1691.99% |
| 2005-12-31 | AU$11.34 Million ≈ $8.02 Million |
AU$1.47 Million ≈ $1.04 Million |
0.130x | -- |
About Cyclopharm Ltd
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribu… Read more